Xiaoou Sun
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Xiaoou Sun has a total of 95 co-authors. Here are the top co-authors by number of shared publications:
- Hao Zhang
Institute of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, Guangzhou 510006, China
10 shared publications - Xingjuan Shi
School of Life Science and Technology, Key Laboratory of Developmental Genes and Human Disease, Southeast University, Nanjing, China
6 shared publications - Wen Tan
Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia, Bandar Sunway 47500, Malaysia
5 shared publications Ying Mei
School of Pharmacy, Jinan University, Guangzhou, 510632, China; YZ Health-tech Inc, Hengqin District, Zhuhai, 519000, China
4 shared publicationsBo Liu
School of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, Guangzhou, 510006, China
3 shared publicationsHao Zhang
Institute of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, Guangzhou, China
3 shared publications
Latest Publications
- Open Access
- 12 November 2026
- Published by Springer Nature in Cell Death & Disease
The FAK-STAT3-XIAP signaling axis couples matrix stiffening to ciliary loss to activate hepatic stellate cells
Activation of hepatic stellate cells (HSCs) is a central event of liver fibrosis, yet the underlying mechanisms remain incompletely understood. Herein, we demonstrate that increased stiffness of extracellular matrix (ECM) is coupled to the loss of primary cilia, which leads to HSC activation in both mouse models and human patients with liver fibrosis. Mechanistically, matrix stiffening triggers the focal adhesion kinase (FAK) and signal transducer and activator of transcription 3 (STAT3) signaling to enhance the expression of X-linked inhibitor of apoptosis protein (XIAP). Upregulation of XIAP promotes the ubiquitination of intraflagellar transport protein 88 (IFT88), leading to its proteasomal degradation and subsequent ciliary loss. The disruption of cilia, in turn, elevates the secretion of ECM components to exacerbate matrix stiffening and HSC activation. Collectively, these findings reveal a positive feedback loop between matrix stiffening and ciliary loss, mediated by the FAK-STAT3-XIAP signaling axis, which promotes HSC activation and liver fibrosis.
- 12 November 2026
- Published by Springer Nature in Cell Death & Disease
Open AccessThe FAK-STAT3-XIAP signaling axis couples matrix stiffening to ciliary loss to activate hepatic stellate cells
Activation of hepatic stellate cells (HSCs) is a central event of liver fibrosis, yet the underlying mechanisms remain incompletely understood. Herein, we demonstrate that increased stiffness of extracellular matrix (ECM) is coupled to the loss of primary cilia, which leads to HSC activation in both mouse models and human patients with liver fibrosis. Mechanistically, matrix stiffening triggers the focal adhesion kinase (FAK) and signal transducer and activator of transcription 3 (STAT3) signaling to enhance the expression of X-linked inhibitor of apoptosis protein (XIAP). Upregulation of XIAP promotes the ubiquitination of intraflagellar transport protein 88 (IFT88), leading to its proteasomal degradation and subsequent ciliary loss. The disruption of cilia, in turn, elevates the secretion of ECM components to exacerbate matrix stiffening and HSC activation. Collectively, these findings reveal a positive feedback loop between matrix stiffening and ciliary loss, mediated by the FAK-STAT3-XIAP signaling axis, which promotes HSC activation and liver fibrosis.
- Open Access
- 21 August 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1) , 10001
CFAP100 forms phase-separated condensates required for ciliary transition zone assembly
Cilia are microtubule-based cellular protrusions critical for cell signaling and motility. The ciliary transition zone connects axonemal microtubules to the ciliary membrane and functions as a gatekeeper by regulating selective targeting and sorting of proteins. However, the molecular mechanisms underlying its assembly remain incompletely understood. Herein, we identify an important role for cilia and flagella associated protein 100 (CFAP100) in the transition zone assembly. Cfap100 knockout mice exhibit ciliary defects in multiple organs, including the brain, trachea, and kidney. Super-resolution imaging reveals that CFAP100 forms a ring-like structure at the distal end of centrioles. Molecular analyses demonstrate that CFAP100 stimulates the transition zone assembly and interacts with nephrocystin-3 (NPHP3), a component of the inversin compartment that localizes adjacent to the transition zone. Further investigation shows that CFAP100 contains an intrinsically disordered region and forms dynamic biomolecular condensates during ciliogenesis, which are sufficient to promote transition zone assembly. Moreover, the phase separation capacity of CFAP100 correlates with its ability to recruit NPHP3. Together, our findings reveal a mechanism through which CFAP100 phase separation promotes ciliary transition zone assembly, providing insights into the physicochemical principle governing ciliogenesis.
- 21 August 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1) , 10001
Open AccessCFAP100 forms phase-separated condensates required for ciliary transition zone assembly
Cilia are microtubule-based cellular protrusions critical for cell signaling and motility. The ciliary transition zone connects axonemal microtubules to the ciliary membrane and functions as a gatekeeper by regulating selective targeting and sorting of proteins. However, the molecular mechanisms underlying its assembly remain incompletely understood. Herein, we identify an important role for cilia and flagella associated protein 100 (CFAP100) in the transition zone assembly. Cfap100 knockout mice exhibit ciliary defects in multiple organs, including the brain, trachea, and kidney. Super-resolution imaging reveals that CFAP100 forms a ring-like structure at the distal end of centrioles. Molecular analyses demonstrate that CFAP100 stimulates the transition zone assembly and interacts with nephrocystin-3 (NPHP3), a component of the inversin compartment that localizes adjacent to the transition zone. Further investigation shows that CFAP100 contains an intrinsically disordered region and forms dynamic biomolecular condensates during ciliogenesis, which are sufficient to promote transition zone assembly. Moreover, the phase separation capacity of CFAP100 correlates with its ability to recruit NPHP3. Together, our findings reveal a mechanism through which CFAP100 phase separation promotes ciliary transition zone assembly, providing insights into the physicochemical principle governing ciliogenesis.
- 2 June 2026
- Published by Elsevier in Ageing Research Reviews
- Vol. 120, 103200
Targeting HDAC6 and its novel E3 ligase activity: A dual-strategy for cardiovascular therapy
- 2 June 2026
- Published by Elsevier in Ageing Research Reviews
- Vol. 120, 103200
Targeting HDAC6 and its novel E3 ligase activity: A dual-strategy for cardiovascular therapy
- Open Access
- 14 February 2026
- Published by Springer Nature in Cellular & Molecular Biology Letters
- Vol. 31 (1)
Extrachromosomal circular DNA: a potential clinical therapeutic target in malignant tumors
Malignant tumors, commonly referred to as cancer, are pathological conditions distinguished by the unregulated growth and infiltration of malignant cells i
- 14 February 2026
- Published by Springer Nature in Cellular & Molecular Biology Letters
- Vol. 31 (1)
Open AccessExtrachromosomal circular DNA: a potential clinical therapeutic target in malignant tumors
Malignant tumors, commonly referred to as cancer, are pathological conditions distinguished by the unregulated growth and infiltration of malignant cells i
- Open Access
- 5 February 2026
- Published by Springer Nature in Cell Biology and Toxicology
- Vol. 42 (1)
METTL7B-stabilized lncRNA-MIR22HG to drive p53-mediated neuronal apoptosis via the ubiquitinating JARID2 in cerebral ischemia/reperfusion injury
Ischemic stroke (IS) constitutes a leading driver of mortality and morbidity worldwide, with neuronal apoptosis representing a key pathological process. Accordingly, our objective was to delve into the implications of a novel signaling axis of the m6A methyltransferase METTL7B, lncRNA-MIR22HG, and JARID2 in driving neuronal apoptosis throughout cerebral ischemia/reperfusion (I/R) injury (CIRI). Mice subjected to middle cerebral artery occlusion/reperfusion (MCAO/R) and N2a cells exposed to oxygen–glucose deprivation/reoxygenation (OGD/R) were, respectively, established as in vivo and in vitro I/R models. METTL7B was markedly up-regulated after I/R and enhanced the m6A methylation and stability of lncRNA-MIR22HG, significantly prolonging its transcript half-life and amplifying its biological effects on neuronal fate. Stabilized lncRNA-MIR22HG suppressed the ubiquitin-mediated degradation of JARID2, thereby increasing JARID2 abundance and activity. Elevated JARID2 promoted the assembly of the p53/p300/MDM2 transcriptional complex, which in turn up-regulated the levels of pro-apoptotic genes, ultimately exacerbating neuronal apoptosis alongside ischemic brain injury. Functionally, METTL7B overexpression aggravated neurological deficits, infarct volume, and neuronal apoptosis in vivo, whereas METTL7B knockdown alleviated ischemic damage and conferred robust neuroprotection. Collectively, these findings define a novel METTL7B/lncRNA-MIR22HG/JARID2 signaling axis that integrates RNA methylation, lncRNA stabilization, proteostasis, and transcriptional activation of apoptosis, and highlight METTL7B as a potential novel target for therapeutic strategies aimed at preventing and treating ischemic stroke. Graphical Abstract Schematic illustration of the METTL7B/lncRNA-MIR22HG/JARID2 signaling axis during cerebral ischemia/reperfusion injury. Ischemic stress up-regulates METTL7B, which enhances m6A methylation and stabilizes MIR22HG. Stabilized lncRNA-MIR22HG prevents ubiquitin-mediated degradation of JARID2, promoting its accumulation. Elevated JARID2 facilitates the assembly of the p53/p300/MDM2 transcriptional complex, leading to transcriptional activation of pro-apoptotic genes (Bax, Puma, Noxa) and aggravation of neuronal apoptosis during I/R injury. 1. METTL7B stabilizes lncRNA-MIR22HG, enhancing neuronal apoptosis in cerebral ischemia/reperfusion injury. 2. MIR22HG prevents the ubiquitin-mediated degradation of JARID2, promoting the p53/p300/MDM2 complex. 3. METTL7B upregulation exacerbates infarct volume, neuronal apoptosis, and neurological deficits. 4. Knockdown of METTL7B offers neuroprotection, highlighting it as a potential therapeutic target.
- 5 February 2026
- Published by Springer Nature in Cell Biology and Toxicology
- Vol. 42 (1)
Open AccessMETTL7B-stabilized lncRNA-MIR22HG to drive p53-mediated neuronal apoptosis via the ubiquitinating JARID2 in cerebral ischemia/reperfusion injury
Ischemic stroke (IS) constitutes a leading driver of mortality and morbidity worldwide, with neuronal apoptosis representing a key pathological process. Accordingly, our objective was to delve into the implications of a novel signaling axis of the m6A methyltransferase METTL7B, lncRNA-MIR22HG, and JARID2 in driving neuronal apoptosis throughout cerebral ischemia/reperfusion (I/R) injury (CIRI). Mice subjected to middle cerebral artery occlusion/reperfusion (MCAO/R) and N2a cells exposed to oxygen–glucose deprivation/reoxygenation (OGD/R) were, respectively, established as in vivo and in vitro I/R models. METTL7B was markedly up-regulated after I/R and enhanced the m6A methylation and stability of lncRNA-MIR22HG, significantly prolonging its transcript half-life and amplifying its biological effects on neuronal fate. Stabilized lncRNA-MIR22HG suppressed the ubiquitin-mediated degradation of JARID2, thereby increasing JARID2 abundance and activity. Elevated JARID2 promoted the assembly of the p53/p300/MDM2 transcriptional complex, which in turn up-regulated the levels of pro-apoptotic genes, ultimately exacerbating neuronal apoptosis alongside ischemic brain injury. Functionally, METTL7B overexpression aggravated neurological deficits, infarct volume, and neuronal apoptosis in vivo, whereas METTL7B knockdown alleviated ischemic damage and conferred robust neuroprotection. Collectively, these findings define a novel METTL7B/lncRNA-MIR22HG/JARID2 signaling axis that integrates RNA methylation, lncRNA stabilization, proteostasis, and transcriptional activation of apoptosis, and highlight METTL7B as a potential novel target for therapeutic strategies aimed at preventing and treating ischemic stroke. Graphical Abstract Schematic illustration of the METTL7B/lncRNA-MIR22HG/JARID2 signaling axis during cerebral ischemia/reperfusion injury. Ischemic stress up-regulates METTL7B, which enhances m6A methylation and stabilizes MIR22HG. Stabilized lncRNA-MIR22HG prevents ubiquitin-mediated degradation of JARID2, promoting its accumulation. Elevated JARID2 facilitates the assembly of the p53/p300/MDM2 transcriptional complex, leading to transcriptional activation of pro-apoptotic genes (Bax, Puma, Noxa) and aggravation of neuronal apoptosis during I/R injury. 1. METTL7B stabilizes lncRNA-MIR22HG, enhancing neuronal apoptosis in cerebral ischemia/reperfusion injury. 2. MIR22HG prevents the ubiquitin-mediated degradation of JARID2, promoting the p53/p300/MDM2 complex. 3. METTL7B upregulation exacerbates infarct volume, neuronal apoptosis, and neurological deficits. 4. Knockdown of METTL7B offers neuroprotection, highlighting it as a potential therapeutic target.
- 1 January 2026
- Published by Springer Nature in Molecular Neurobiology
- Vol. 63 (1) , 447
H3K27ac-Activated lncRNA-DAPK1-IT1 Aggravated Oxidative Stress Damage Induced by Focal Cerebral Ischemia/Reperfusion via the miR-25-3p/HMGB1 Molecular Axis
Ischemic stroke is a prevalent neurological disorder, characterized by elevated mortality and significant long-term disability. Oxidative stress damage is an important pathological process that occurs after brain ischemia/reperfusion (I/R), in which the long non-coding RNA death-associated protein kinase 1 intronic transcript 1 (DAPK1-IT1) is aberrantly expressed and participates in oxidative stress damage; however, its specific mechanisms of action remain unclear. DAPK1-IT1 and miR-25-3p expression was detected using qRT-PCR in the mouse neuroblastoma N2a cells that received middle cerebral artery occlusion/reperfusion and oxygen-glucose deprivation/reperfusion. Functional gain and loss experiments were performed to manipulate DAPK1-IT1, miR-25-3p, and HMGB1 expression. The role of DAPK1-IT1 was assessed both in vivo and in vitro using CCK-8, flow cytometry, and western blotting. The results showed that the levels of DAPK1-IT1, HMGB1, and oxidative stress damage markers were significantly increased, whereas miR-25-3p expression was significantly downregulated. The expression levels of DAPK1-IT1 were positively correlated with ROS production. DAPK1-IT1 and HMGB1 were identified as potential targets of miR-25-3p. Knockdown of DAPK1-IT1 and HMGB1, as well as overexpression of miR-25-3p, is indeed protective and contribute to reducing oxidative stress damage by activating the Nrf2/HO-1 signaling pathway. DAPK1-IT1 overexpression caused oxidative stress damage in N2a cells by downregulating miR-25-3p expression and upregulating HMGB1 expression. Mechanistically, DAPK1-IT1 upregulated HMGB1 expression by sponging miR-25-3p and mediating histone H3 lysine 27 acetylation in the promoter region through the cAMP response element-binding protein-binding protein (CBP). In summary, we found that H3K27 acetylation-induced lncRNA-DAPK1-IT1 promotes oxidative stress damage caused by I/R through the miR-25-3p/HMGB1 axis. These findings help to improve our understanding of ischemic stroke and provide new therapeutic avenues.
- 1 January 2026
- Published by Springer Nature in Molecular Neurobiology
- Vol. 63 (1) , 447
H3K27ac-Activated lncRNA-DAPK1-IT1 Aggravated Oxidative Stress Damage Induced by Focal Cerebral Ischemia/Reperfusion via the miR-25-3p/HMGB1 Molecular Axis
Ischemic stroke is a prevalent neurological disorder, characterized by elevated mortality and significant long-term disability. Oxidative stress damage is an important pathological process that occurs after brain ischemia/reperfusion (I/R), in which the long non-coding RNA death-associated protein kinase 1 intronic transcript 1 (DAPK1-IT1) is aberrantly expressed and participates in oxidative stress damage; however, its specific mechanisms of action remain unclear. DAPK1-IT1 and miR-25-3p expression was detected using qRT-PCR in the mouse neuroblastoma N2a cells that received middle cerebral artery occlusion/reperfusion and oxygen-glucose deprivation/reperfusion. Functional gain and loss experiments were performed to manipulate DAPK1-IT1, miR-25-3p, and HMGB1 expression. The role of DAPK1-IT1 was assessed both in vivo and in vitro using CCK-8, flow cytometry, and western blotting. The results showed that the levels of DAPK1-IT1, HMGB1, and oxidative stress damage markers were significantly increased, whereas miR-25-3p expression was significantly downregulated. The expression levels of DAPK1-IT1 were positively correlated with ROS production. DAPK1-IT1 and HMGB1 were identified as potential targets of miR-25-3p. Knockdown of DAPK1-IT1 and HMGB1, as well as overexpression of miR-25-3p, is indeed protective and contribute to reducing oxidative stress damage by activating the Nrf2/HO-1 signaling pathway. DAPK1-IT1 overexpression caused oxidative stress damage in N2a cells by downregulating miR-25-3p expression and upregulating HMGB1 expression. Mechanistically, DAPK1-IT1 upregulated HMGB1 expression by sponging miR-25-3p and mediating histone H3 lysine 27 acetylation in the promoter region through the cAMP response element-binding protein-binding protein (CBP). In summary, we found that H3K27 acetylation-induced lncRNA-DAPK1-IT1 promotes oxidative stress damage caused by I/R through the miR-25-3p/HMGB1 axis. These findings help to improve our understanding of ischemic stroke and provide new therapeutic avenues.
- 24 December 2025
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 278, 108972
N6-methyladenosine (m6A) RNA methylation: a potential clinical therapeutic target in cardiocerebrovascular diseases
- 24 December 2025
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 278, 108972
N6-methyladenosine (m6A) RNA methylation: a potential clinical therapeutic target in cardiocerebrovascular diseases
- Open Access
- 7 October 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (19) , 9756
Long Non-Coding RNA 1810026B05Rik Mediates Cerebral Ischemia/Reperfusion-Induced Neuronal Injury Through NF-κB Pathway Activation
Cerebral ischemia/reperfusion (I/R) injury remains a significant contributor to adult neurological morbidity, primarily due to exacerbated neuroinflammation and cell apoptosis. These processes amplify brain damage through the release of various pro-inflammatory cytokines and pro-apoptotic mediators. Although long non-coding RNAs (lncRNAs) are increasingly recognized for their involvement in regulating diverse biological pathways, their precise role in cerebral I/R injury has not been fully elucidated. In the current study, transcriptomic profiling was conducted using a rat model of focal cerebral I/R, leading to the identification of lncRNA-1810026B05Rik—also referred to as CHASERR—as a novel lncRNA responsive to ischemic conditions. The elevated expression of this lncRNA was observed in mouse brain tissues subjected to middle cerebral artery occlusion followed by reperfusion (MCAO/R), as well as in primary cortical neurons derived from rats exposed to oxygen-glucose deprivation and subsequent reoxygenation (OGD/R). The results suggested that lncRNA-1810026B05RiK mediates the activation of the nuclear factor-kappaB (NF-κB) signaling pathway by physically binding to NF-kappa-B inhibitor alpha (IκBα) and promoting its phosphorylation, thus leading to neuroinflammation and neuronal apoptosis during cerebral ischemia/reperfusion. In addition, lncRNA-1810026B05Rik knockdown acts as an NF-κB inhibitor in the OGD/R and MCAO/R pathological processes, suggesting that lncRNA-1810026B05Rik downregulation exerts a protective effect on cerebral I/R injury. In summary, the lncRNA-1810026B05Rik has been identified as a critical regulator of neuronal apoptosis and inflammation through the activation of the NF-κB signaling cascade. This discovery uncovers a previously unrecognized role of 1810026B05Rik in the molecular mechanisms underlying ischemic stroke, offering valuable insights into disease pathology. Moreover, its involvement highlights its potential as a novel therapeutic target, paving the way for innovative treatment strategies for stroke patients.
- 7 October 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (19) , 9756
Open AccessLong Non-Coding RNA 1810026B05Rik Mediates Cerebral Ischemia/Reperfusion-Induced Neuronal Injury Through NF-κB Pathway Activation
Cerebral ischemia/reperfusion (I/R) injury remains a significant contributor to adult neurological morbidity, primarily due to exacerbated neuroinflammation and cell apoptosis. These processes amplify brain damage through the release of various pro-inflammatory cytokines and pro-apoptotic mediators. Although long non-coding RNAs (lncRNAs) are increasingly recognized for their involvement in regulating diverse biological pathways, their precise role in cerebral I/R injury has not been fully elucidated. In the current study, transcriptomic profiling was conducted using a rat model of focal cerebral I/R, leading to the identification of lncRNA-1810026B05Rik—also referred to as CHASERR—as a novel lncRNA responsive to ischemic conditions. The elevated expression of this lncRNA was observed in mouse brain tissues subjected to middle cerebral artery occlusion followed by reperfusion (MCAO/R), as well as in primary cortical neurons derived from rats exposed to oxygen-glucose deprivation and subsequent reoxygenation (OGD/R). The results suggested that lncRNA-1810026B05RiK mediates the activation of the nuclear factor-kappaB (NF-κB) signaling pathway by physically binding to NF-kappa-B inhibitor alpha (IκBα) and promoting its phosphorylation, thus leading to neuroinflammation and neuronal apoptosis during cerebral ischemia/reperfusion. In addition, lncRNA-1810026B05Rik knockdown acts as an NF-κB inhibitor in the OGD/R and MCAO/R pathological processes, suggesting that lncRNA-1810026B05Rik downregulation exerts a protective effect on cerebral I/R injury. In summary, the lncRNA-1810026B05Rik has been identified as a critical regulator of neuronal apoptosis and inflammation through the activation of the NF-κB signaling cascade. This discovery uncovers a previously unrecognized role of 1810026B05Rik in the molecular mechanisms underlying ischemic stroke, offering valuable insights into disease pathology. Moreover, its involvement highlights its potential as a novel therapeutic target, paving the way for innovative treatment strategies for stroke patients.
- Open Access
- 24 September 2025
- Published by MDPI AG in Biomolecules
- Vol. 15 (10) , 1353
METTL3-Driven m6A Epigenetic Remodeling of lncRNA-AU020206 Stabilizes SLC7A11 via YTHDC2 Attenuates Apoptosis and Ferroptosis in Cerebral Ischemia/Reperfusion Injury
Cerebral ischemia/reperfusion (I/R) injury is a devastating neurological disorder with limited treatment options. Emerging evidence suggests that the N6-methyladenosine (m6A) modification and its regulatory factors play pivotal roles in the pathophysiology of I/R. This study aimed to elucidate the function of METTL3-mediated m6A modification of the long non-coding RNA (lncRNA) AU020206 in ferroptosis during cerebral I/R injury and to identify potential molecular targets for neuroprotection. A murine model of middle cerebral artery occlusion/reperfusion (MCAO/R) and N2a cells subjected to oxygen–glucose deprivation/reoxygenation (OGD/R) were established to assess m6A levels and ferroptosis-related changes. Effects of METTL3 overexpression and lncRNA-AU020206 silencing on neuronal apoptosis, inflammation, and ferroptosis were investigated in vitro and in vivo. The interaction between lncRNA-AU020206 and YTHDC2 and the resulting regulation of SLC7A11 mRNA stability and GPX4 expression were evaluated using molecular and biochemical assays. Both MCAO/R mice and OGD/R-treated N2a cells exhibited decreased m6A levels and upregulation of lncRNA-AU020206 accompanied by enhanced ferroptosis. METTL3 overexpression increased the m6A modification of AU020206, promoting its degradation and attenuating neuronal injury, whereas silencing AU020206 or overexpressing YTHDC2 decreased SLC7A11 mRNA stability and enhanced ferroptosis. Restoring the expression of SLC7A11/GPX4 can enhance cell viability, alleviate neuronal apoptosis, and reduce Fe2+ overload. Disruption of the METTL3–AU020206–YTHDC2 axis abolished these neuroprotective effects. METTL3-mediated m6A modification of lncRNA-AU020206 restrained ferroptosis and neuronal injury in cerebral I/R by maintaining the stability of the SLC7A11/GPX4 axis via interactions with YTHDC2. Targeting this epitranscriptomic signalling pathway may represent a promising therapeutic strategy for the treatment of ischemic stroke and related neurological disorders.
- 24 September 2025
- Published by MDPI AG in Biomolecules
- Vol. 15 (10) , 1353
Open AccessMETTL3-Driven m6A Epigenetic Remodeling of lncRNA-AU020206 Stabilizes SLC7A11 via YTHDC2 Attenuates Apoptosis and Ferroptosis in Cerebral Ischemia/Reperfusion Injury
Cerebral ischemia/reperfusion (I/R) injury is a devastating neurological disorder with limited treatment options. Emerging evidence suggests that the N6-methyladenosine (m6A) modification and its regulatory factors play pivotal roles in the pathophysiology of I/R. This study aimed to elucidate the function of METTL3-mediated m6A modification of the long non-coding RNA (lncRNA) AU020206 in ferroptosis during cerebral I/R injury and to identify potential molecular targets for neuroprotection. A murine model of middle cerebral artery occlusion/reperfusion (MCAO/R) and N2a cells subjected to oxygen–glucose deprivation/reoxygenation (OGD/R) were established to assess m6A levels and ferroptosis-related changes. Effects of METTL3 overexpression and lncRNA-AU020206 silencing on neuronal apoptosis, inflammation, and ferroptosis were investigated in vitro and in vivo. The interaction between lncRNA-AU020206 and YTHDC2 and the resulting regulation of SLC7A11 mRNA stability and GPX4 expression were evaluated using molecular and biochemical assays. Both MCAO/R mice and OGD/R-treated N2a cells exhibited decreased m6A levels and upregulation of lncRNA-AU020206 accompanied by enhanced ferroptosis. METTL3 overexpression increased the m6A modification of AU020206, promoting its degradation and attenuating neuronal injury, whereas silencing AU020206 or overexpressing YTHDC2 decreased SLC7A11 mRNA stability and enhanced ferroptosis. Restoring the expression of SLC7A11/GPX4 can enhance cell viability, alleviate neuronal apoptosis, and reduce Fe2+ overload. Disruption of the METTL3–AU020206–YTHDC2 axis abolished these neuroprotective effects. METTL3-mediated m6A modification of lncRNA-AU020206 restrained ferroptosis and neuronal injury in cerebral I/R by maintaining the stability of the SLC7A11/GPX4 axis via interactions with YTHDC2. Targeting this epitranscriptomic signalling pathway may represent a promising therapeutic strategy for the treatment of ischemic stroke and related neurological disorders.
- 18 March 2024
- Published by Springer Nature in Human Cell
- Vol. 37 (3) , 607-624
The role of cardiac microenvironment in cardiovascular diseases: implications for therapy
Due to aging populations and changes in lifestyle, cardiovascular diseases including cardiomyopathy, hypertension, and atherosclerosis, are the leading causes of death worldwide. The heart is a complicated organ composed of multicellular types, including cardiomyocytes, fibroblasts, endothelial cells, vascular smooth muscle cells, and immune cells. Cellular specialization and complex interplay between different cell types are crucial for the cardiac tissue homeostasis and coordinated function of the heart. Mounting studies have demonstrated that dysfunctional cells and disordered cardiac microenvironment are closely associated with the pathogenesis of various cardiovascular diseases. In this paper, we discuss the composition and the homeostasis of cardiac tissues, and focus on the role of cardiac environment and underlying molecular mechanisms in various cardiovascular diseases. Besides, we elucidate the novel treatment for cardiovascular diseases, including stem cell therapy and targeted therapy. Clarification of these issues may provide novel insights into the prevention and potential targets for cardiovascular diseases.
- 18 March 2024
- Published by Springer Nature in Human Cell
- Vol. 37 (3) , 607-624
The role of cardiac microenvironment in cardiovascular diseases: implications for therapy
Due to aging populations and changes in lifestyle, cardiovascular diseases including cardiomyopathy, hypertension, and atherosclerosis, are the leading causes of death worldwide. The heart is a complicated organ composed of multicellular types, including cardiomyocytes, fibroblasts, endothelial cells, vascular smooth muscle cells, and immune cells. Cellular specialization and complex interplay between different cell types are crucial for the cardiac tissue homeostasis and coordinated function of the heart. Mounting studies have demonstrated that dysfunctional cells and disordered cardiac microenvironment are closely associated with the pathogenesis of various cardiovascular diseases. In this paper, we discuss the composition and the homeostasis of cardiac tissues, and focus on the role of cardiac environment and underlying molecular mechanisms in various cardiovascular diseases. Besides, we elucidate the novel treatment for cardiovascular diseases, including stem cell therapy and targeted therapy. Clarification of these issues may provide novel insights into the prevention and potential targets for cardiovascular diseases.